Alteration of glomerulogenesis- and podocyte structure-related gene expression in early diabetic nephropathy

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Diabetic nephropathy is a primary cause of end-stage renal disease.
• The renin-angiotensin system and glomerulogenesis-related molecules are implicated in its pathogenesis.
• These molecules play a role, particularly in the early, normoalbuminuric stage of diabetic nephropathy.

Purpose of the Study:

• To investigate the role of glomerulogenesis-related molecules in diabetic nephropathy.
• To identify specific molecular pathways involved in early-stage diabetic kidney disease.
• To explore potential therapeutic targets for preventing diabetic nephropathy.

Main Methods:

• Analysis of glomerulogenesis-related molecules involved in fibrosis, podocyte differentiation, and angiogenesis.
• Examination of molecular expression in podocytes during normoalbuminuric and later stages.
• Assessment of alterations in podocyte structure-related molecules.

Main Results:

• Glomerulogenesis-related molecules are upregulated in podocytes, even in the normoalbuminuric stage.
• Expression of podocyte structure-related molecules is altered early in diabetic nephropathy.
• These molecular changes contribute to podocyte structural alterations.

Conclusions:

• Glomerulogenesis-related molecules are key players in the early pathogenesis of diabetic nephropathy.
• Altered expression of these molecules, including structural ones, occurs before overt albuminuria.
• Normalization of glomerulogenesis-related molecule expression presents a novel therapeutic strategy for diabetic kidney disease.